Search results
Sanders drops subpoena effort after Novo Nordisk CEO agrees to testify
The Hill· 16 hours agoSanders announced earlier this week that he would hold a vote to subpoena Doug Langa, the executive...
BofA lifts Novo Nordisk price target on EPS upside potential, upcoming pipeline data By...
Investing.com· 1 day agoBank of America lifted its target price on Novo Nordisk’s (NVO) Denmark-listed shares to DKK 1,150...
Bernie Sanders Wants to Subpoena Novo Nordisk Over Wegovy’s Price. What to Know.
Barrons.com· 3 days agosemaglutide, the active ingredient in Wegovy and Ozempic, to be selected for price negotiation...
Sanders calls vote to subpoena Novo Nordisk president
Becker’s Hospital Review· 4 days agoFollowing jousts between Vermont Sen. Bernie Sanders and Novo Nordisk, the Senate Committee on Health, Education, Labor, and Pensions will vote June 18 ...
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
Motley Fool via Yahoo Finance· 1 day agoThat's not a bad price to invest in a reliable dividend payer that should deliver steady returns for...
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time...
Motley Fool via Yahoo Finance· 4 days agoConsider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our...
Making the case for Wegovy coverage: Drug keeps weight off for 4 years, aids heart health
BenefitsPRO· 4 days agoDrugmaker Novo Nordisk has released two new trial results that could strengthen the case for...
Daily Brief: World’s most valuable
Quartz· 3 days agoWedbush analyst Dan Ives made the prediction in a research note yesterday. Tesla investors are voting on Elon Musk’s pay today. If investors re-approve...
Why Home-Builder Stocks Can Continue Their Bull Run
Barrons.com· 21 hours agoHome inventory is up, but still very low and prices remain high. That means builder profits should remain fat. Plus, exploiting the rush to obesity...
Structure Therapeutics (GPCR) Rallying on Obesity Drug Data
Zacks via Yahoo Finance· 4 days agoStructure Therapeutics (GPCR) stock sees an upside on positive top-line data from a phase IIa...